Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)
Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)
Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)-RA0432-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
ELISA plate pre-coated Antigen protein, can bind Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)-RA0432 in a linear range of 3.91-125 ng/mL.
Etaracizumab (Biosimilar Reference Antibody) (ITGAVB3)

Catalog: 

RA0432

Target

ITGAVB3/CD61/VNR

Isotype

IgG1 - kappa

Applications

ELISA;FC;Functional Assays;IF

Reactivities

Human

Size ($):

100 μg-50;1 mg-210;5 mg-500;10 mg-800;25 mg-1750;50 mg-3000;100 mg-4600

Data Sheet

Material Safety Data Sheet

Certificate of Analysis

Product Description

Etaracizumab is a humanized monoclonal IgG1 antibody developed as an anti-angiogenic therapy for the treatment of solid tumors. It functions as a selective integrin antagonist, specifically designed to block a key receptor involved in new blood vessel formation (angiogenesis) and tumor cell migration. By binding with high affinity to its target integrin on the surface of proliferating endothelial cells and some tumor cells, etaracizumab inhibits their interaction with extracellular matrix proteins. This blockade disrupts critical signaling pathways necessary for endothelial cell survival, migration, and capillary tube formation, thereby starving the tumor of its blood supply and potentially inhibiting its growth and spread.

Synonyms

hLM60, MEDI-522

CAS

892553-42-3

Isotype

IgG1 - kappa

Host

Humanised

Target

ITGAVB3/CD61/VNR

Reactivity

Human

Expression System

CHO

Applications

ELISA, FC, Functional Assays, IF; Recommended dilution: FC, IF:1:200

Purity

>98% by SDS-PAGE

Concentration

Bottled at the concentration indicated on the vial.

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Endotoxin

<1.0 EU/mg as determined by LAL method

Conjugation

Non-conjugated

Formulation

Liquid or Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Storage

store at -20°C or -80°C. Avoid repeated freeze.

Type

Antibody

Purposes

For research use only

References 1

Hersey P, et al. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma. Cancer. 2010 Mar 15;116(6):1526-34.

References 2

Delbaldo, C., et al., (2008). Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors. Investigational new drugs, 26(1), 35–43.

References 3

References 4

References 5

Product Citations 1

Product Citations 2

https://pubmed.ncbi.nlm.nih.gov/20108344/
https://pubmed.ncbi.nlm.nih.gov/17876527/

Target Description

Synonyms

integrin alphaV_beta3, integrin αVβ3, CD51_GPIIIa, vitronectin receptor, VNR, CD51_CD61

Biology Area

Cancer Biology;Angiogenesis;CD Markers

Function

integrin αvβ3 (alpha-v beta-3), a heterodimeric transmembrane receptor that mediates cell adhesion and signaling. Integrin αvβ3 is expressed at low levels on normal, quiescent endothelial cells and some osteoclasts but becomes highly upregulated on activated endothelial cells within growing tumor vasculature and on certain aggressive tumor cells (e.g., melanoma, glioblastoma). It recognizes ligands in the extracellular matrix containing an Arg-Gly-Asp (RGD) amino acid sequence, such as vitronectin, fibronectin, and osteopontin. Upon ligand binding, αvβ3 activates intracellular signaling cascades (e.g., via FAK and Src kinases) that promote endothelial cell migration, proliferation, and survival during angiogenesis, as well as tumor cell invasion and metastasis.

Additional Articles 1

Additional Articles 2

Related Products

Catalog: 

RA0432

Target:

CD274/PDL1/B7H1

Isotype:

IgG - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0432

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0432

Target:

IL6R/CD126

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0432

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0432

Target:

IL7R/CD127

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0432

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0432

Target:

IL7R/CD127

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0432

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0432

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0432

Target:

IL9

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Contact Us

Send your request

Talk to us 

Get a quotation, discuss your requirement, receive advises from our antibody experts without obligation.